Info: info@gianlucatagliapietra.com 


linkedin

For more information:

info@gianlucatagliapietra.com

Gianluca Tagliapietra

Transformational Strategic Global Executive


linkedin
whatsapp

Gianluca Tagliapietra

Transformational Strategic Global Executive

immagine_percorso_2.jpeg

Executive Profile

 

Strategic Planning & Execution / C-Level Communication / Account Management & Development / Non Executive Director

Commercial Operations / Detailed Market Research / Profit & Loss Administration / Global Sales / Digital BTB

 

Senior Commercial Executive with 20+ years leading high-impact sales operations across EMEA and global markets in the pharmaceutical, life sciences, and healthcare industries. Proven expertise in strategic planning, business development, and multi-channel sales management generating revenues exceeding €1.2 billion annually. Skilled in transforming commercial operations with data-driven processes and digital tools, building and leading cross-functional teams, and fostering long-term client partnerships with top global corporations. Excellent communicator adept at C-level stakeholder engagement and large-scale contract negotiations.

 

  • Sales Strategy & Execution
  • Global Account Management
  • Commercial Operations Leadership
  • P&L Management & Profit Optimization
  • Digital Transformation in Sales
  • High-Performing Team Leadership
  • Multimarket & Cross-cultural Experience
  • General Management
  • New Business Development
  • Change Management

Experience

 

Merck Group (2010 – December 2025)

 

Senior Vice President Commercial EMEA (2022 to 2025)

  • Lead end-to-end commercial sales and operations for €1.2B across Europe, the Middle East, and Africa, directing a high-performing organization of 1,100+ professionals.
  • Oversee all revenue-critical functions including account management, pricing, sales support, customer care, credit collection, tactical marketing, e-commerce/BTB platform integration, and technical CRM teams—ensuring sustained market expansion and superior client retention.
  • Implemented scalable, data-driven processes that increased efficiency, strengthened accountability, and accelerated top-line growth in highly competitive markets.
  • Manage and optimize the entire EMEA distributor network and global export operations, driving profitable channel performance.

 

Vice President Global Accounts & Distributors (2017 to 2022)

  • Directed €600M in global sales, overseeing both strategic accounts and distributor-driven channels.
  • Led the Global Strategic Pharmaceutical Accounts portfolio, managing 15+ top-tier clients and delivering €250M in annual revenue.
  • Oversaw a network of 1,000+ distributors across EMEA and the USA, generating €350M in direct sales, and managed the global distributors program supporting €600M in worldwide sales.
  • Successfully renegotiated key distributor contracts worth €300M, significantly improving retention, profitability, and long-term partnership value.
  • Redesigned global ‘Go-to-Market’ strategies, enabling 13% distributor network growth, outperforming the 3% market average.

 

Vice President Global Strategic Accounts Pharma (2016 to 2017)

  • Developed global strategic account programs with a focus on top pharmaceutical firms, supported by cross-functional scientific sales teams.
  • Established five-year plans that expanded client base and solidified market leadership.

 

Sigma Aldrich - now part of Merck

 

Senior Director Global Accounts & Europe (2013 to 2016)

Managing Director Italy - (2011 to 2014)

Sales Director Central & South Europe - Sigma Aldrich - Now Part of Merck (2010 to 2013)

  • Led commercial organisations across multiple European countries, enhancing operational capabilities and market penetration.

Additional Experiences

Miltenyi Biotec GmbH (1999 – 2010)

 

European Sales & Marketing Manager (2006 – 2010)

CEO (Head of Board of Directors) Italy (1999 – 2010) – Start-up

  • Founded and managed the Italian branch, delivering sustained revenue growth in innovative biotech segments.

Head of Apheresis Business Unit (2002 – 2006)

 

Gambro S.P.A. COBE BCT Division – today Terumo BCT (1992 – 1999)

 

Sales & Clinical Specialist

  • Provided clinical sales expertise in blood treatment technology products across Italy.

Education and Credentials

  • Master of Business Administration- Global Executive (MBA) - SDA Bocconi School of Management – Milan, 2016 - Elective modules at: UCLA (U.S.A.), Fudan University (Shanghai, China), Copenhagen University, FIA (San Paolo, Brazil), UCLA (U.S.A.)
  • Managing Innovation in the Era of Data and AI (MIDA) – EPFL Lausanne 2025
  • Advanced Leadership Programs — Stanford University & INSEAD (Merck University) 2018
  • General Management Program — Babson College, USA, 2017
  • Executive Education — Washington University, St. Louis, 2013
  • Political & Organisational Sciences - Bologna University – Italy, 2013

Skills

 

Italian (mother tongue) | English (Fluent) | French (Basic) | Spanish (Basic)|Strategic partnership | Start-up | Executive Management | Entrepreneurship | Digital Sales | Recruiting | General Management | Non Executive Director